Skip to content

Cerebral Palsy Adult Transition Longitudinal Study

Walking and Its Effect on Health and Function in Individuals With Cerebral Palsy as They Transition to Adulthood: A Health Outcomes Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02137005
Acronym
CPAT
Enrollment
72
Registered
2014-05-13
Start date
2014-05-01
Completion date
2027-12-01
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Keywords

walking, gait disorders, neurologic, health status, cognition, quality of life, Transition to Adult Care

Brief summary

The purpose of this study is to investigate longitudinally, the walking ability of individuals with cerebral palsy who are transitioning into adulthood and to cross-sectionally examine the health status of these individuals in the context of their walking ability. Young adults who received instrumented gait analysis (IGA) as children will show significant decreases in overall gait performance, as measured by kinematics, kinetics, temporal-spatial parameters, and gait deviation index, compared to their last childhood IGA.

Detailed description

The investigators are proposing a prospective, longitudinal, cross-sectional, and patient-centered outcome study of walking ability and current health status to investigate important health outcomes that impact the quality of life, participation, and activity on adults with cerebral palsy who took part in a gait analysis during childhood at the Center for Gait and Movement Analysis (CGMA). The goal is to see whether their health and walking ability has changed since leaving the Children's Hospital Colorado (CHCO) system and understand if there is a relationship between maintaining proper walking ability and health status. The investigators are including the measure of health outcomes to better understand if a decline in walking ability relates to a decline in health status. The first aim is to study the walking ability of adults with cerebral palsy by comparing their results of a gait analysis to the same results collected when they were children. The second aim is to study the presence of heart disease risk factors by testing each participant's blood levels of lipids, glucose, and insulin. The investigators will also measure each participant's blood pressure. The third aim is to study the relationship(s) between inflammatory markers, neurotrophic factors, and pain and fatigue levels. The investigators will measure inflammatory markers through a blood test and pain and fatigue levels through standardized assessments. The fourth aim is to study each participant's mental health. The investigators will measure this through standardized psychological assessments. The fifth aim is to study each participant's self-perceived health and quality of life as well as employment status. The investigators will measure these levels also through standardized assessments.

Interventions

None listed

Sponsors

University of Colorado, Denver
Lead SponsorOTHER
Children's Hospital Colorado
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Male and female adults (aged 18 years or older) with cerebral palsy (CP) * Adults with CP who are part of the CGMA data registry * Adults with CP who have previously participated in an IGA at the CGMA * Adults with CP who are able to walk (with or without assistance) three times down a \~35 foot walkway at a comfortable and self-selected pace * Adults with CP who are able to give informed consent, or have a legally authorized representative to give informed consent * Adults with CP who are able to understand and communicate in English or Spanish (medical interpreters will be utilized for this study when needed) * If medicated, adults with CP will need to be on a stable medication regimen for at least six months prior to study enrollment (including non-steroidal anti-inflammatory drugs (NSAIDs)) * Adults with CP who are able to devote sufficient time to participate in a health/physical exam, respond to questions asked during assessments, and participate in an IGA * Adults with CP who have no recent history of seizure or blackout

Exclusion criteria

* Male and female children (aged 17 years or younger) with CP * Adults with CP who have never participated in an IGA at the CGMA * Adults with CP whose mobility is impaired to the point of being unable to move (even with assistance) * Adults with CP who are taking any medication(s) that might interfere with the ability to move * Adults with CP who are unable to devote sufficient time to participate in a health/physical exam, respond to questions asked during assessments, and participate in an IGA * Adults with CP who have any medical issue impacting performance

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline Instrumented Gait Analysis (IGA) at up to 15 yearsbaseline and up to 15 yearsKinematics - joint angles and positions during over-ground walking. Kinetics - forces measured from force plates during over-ground walking. Gait Deviation Index - overall gait performance score measured from kinematics. Electromyography - measure of muscle activity during over-ground walking. Physical Exam - measure of joint range of motion and muscle strength.

Secondary

MeasureTime frameDescription
Metabolic, Inflammatory, and Neurotrophic Markers Blood Samplesone time-point cross-sectional studyBlood will be drawn during 1 study visit after fasting for 12 hours. Several different blood analyses will be run on the sample. Blood will not be banked.
Fatigue Measureone time-point cross-sectional studyMuscle fatigue will be measured by the Moreau Fatigue Index. This test is performed by doing repeated maximum voluntary concentric knee flexion and extensions at 60 degrees/sec for 35 repetitions.
NIH Patient Reported Outcomes Measurement System (PROMIS) and Health-Related Quality of Lifeone time-point cross-sectional studyQuestionnaire measures of patients symptoms, functioning, and health-related quality of life.
Employment Statusone time-point cross-sectional studyDemographic data collection using a questionnaire.
The World Health Organization Disability Assessment Schedule (WHODAS II)one time-point cross-sectional studyInstrument providing a global measure of disability across six domains.
Self-Efficacyone time-point cross-sectional studyGeneral Self-Efficacy Scale-12 (GSES-12) assess a general sense of perceived self-efficacy with th eaim to evaluate coping with daily hassles as well as adaptation after experiencing stressful life events
Life Style Assessmentsone time-point cross-sectional studySelf-Rated Abilities for Health Practices Scale (SRAHP) - 28-item 5-point scale to measure self-perceived ability to implement health-promoting behaviors. Comprehensive Health Assessment Motivation Program (CHAMP)/Health \& Wellness Passport - checklist of daily lifestyle and fitness choices that contribute to individuals personal success.
Cognitive Batteryone time-point cross-sectional studySubtests of Wechsler Adult Intelligence Score IV/Wechsler Memory Scale IV (WAIS IV/WMS IV) - standardized psychological evaluation. Verbal Fluency - subject generates as many words belonging to one semantic category. NIH Toolbox Cognitive Battery - computerized adaptive test principles to measure cognitive function.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJames J Carollo, Ph.D.

University of Colorado Denver, Anschutz Medical Campus

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 9, 2026